Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation

Shoji Kutsuki, Uematsu Minoru, Makoto Kondo, Naoyuki Shigematsu, Osamu Kawaguti, Takatsugu Kawase, Akitomo Sugawara, Hisao Ito, Atsushi Kubo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Radiation therapy is the treatment of choice for early stage low grade non-Hodgkin’s lymphoma (ESLGNHL) of nodal presentation. However, the optimal radiation field is still controversial. We used various radiation fields for this low grade malignancy, and evaluated the results. Materials and methods: Between 1983 and 1993, 14 patients with ESLGNHL were treated with radiation therapy. Five of them received involved field (IF) radiation, 4 regional irradiation (RF), and 5 total lymphoid irradiation (TLI). Results: With a median follow up period of 10 years, 8 of the 14 patients were alive and disease free. Relapse occured in 2 of 5 patients treated with IF, 2 of 4 with RF, and 2 of 5 with TLI. Two patients relapsed following IF had marginal failure, and were salvaged by additional radiation therapy. One patient relapsed following RF had transdiaphragmatic nodal failure, one patient followed TLI relapsed in a non-irradiated area caused by field-matching error. Only one patient with histological transformation into aggressive lymphoma died of disease, and the remaining 5 relapsed patients were alive with or without ESLGNHL. Conclusion: Larger field radiation therapy may reduce nodal and/or marginal failure in patients with ESLGNHL. However without histologic transformation, relapse of ESLGNHL could be salvaged by additional treatment.

Original languageEnglish
Pages (from-to)131-136
Number of pages6
JournalJournal of JASTRO
Volume12
Issue number2
DOIs
Publication statusPublished - 2000

Fingerprint

Non-Hodgkin's Lymphoma
Radiotherapy
Lymphatic Irradiation
Radiation
Recurrence
Lymphoma
Therapeutics

Keywords

  • Early stage low grade non-Hodgkin’s
  • Lymphoma
  • Total lymphoid irradiation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation. / Kutsuki, Shoji; Minoru, Uematsu; Kondo, Makoto; Shigematsu, Naoyuki; Kawaguti, Osamu; Kawase, Takatsugu; Sugawara, Akitomo; Ito, Hisao; Kubo, Atsushi.

In: Journal of JASTRO, Vol. 12, No. 2, 2000, p. 131-136.

Research output: Contribution to journalArticle

Kutsuki, S, Minoru, U, Kondo, M, Shigematsu, N, Kawaguti, O, Kawase, T, Sugawara, A, Ito, H & Kubo, A 2000, 'Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation', Journal of JASTRO, vol. 12, no. 2, pp. 131-136. https://doi.org/10.11182/jastro1989.12.131
Kutsuki, Shoji ; Minoru, Uematsu ; Kondo, Makoto ; Shigematsu, Naoyuki ; Kawaguti, Osamu ; Kawase, Takatsugu ; Sugawara, Akitomo ; Ito, Hisao ; Kubo, Atsushi. / Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation. In: Journal of JASTRO. 2000 ; Vol. 12, No. 2. pp. 131-136.
@article{3ea1e22176a04125b2beeda97da9667e,
title = "Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation",
abstract = "Purpose: Radiation therapy is the treatment of choice for early stage low grade non-Hodgkin’s lymphoma (ESLGNHL) of nodal presentation. However, the optimal radiation field is still controversial. We used various radiation fields for this low grade malignancy, and evaluated the results. Materials and methods: Between 1983 and 1993, 14 patients with ESLGNHL were treated with radiation therapy. Five of them received involved field (IF) radiation, 4 regional irradiation (RF), and 5 total lymphoid irradiation (TLI). Results: With a median follow up period of 10 years, 8 of the 14 patients were alive and disease free. Relapse occured in 2 of 5 patients treated with IF, 2 of 4 with RF, and 2 of 5 with TLI. Two patients relapsed following IF had marginal failure, and were salvaged by additional radiation therapy. One patient relapsed following RF had transdiaphragmatic nodal failure, one patient followed TLI relapsed in a non-irradiated area caused by field-matching error. Only one patient with histological transformation into aggressive lymphoma died of disease, and the remaining 5 relapsed patients were alive with or without ESLGNHL. Conclusion: Larger field radiation therapy may reduce nodal and/or marginal failure in patients with ESLGNHL. However without histologic transformation, relapse of ESLGNHL could be salvaged by additional treatment.",
keywords = "Early stage low grade non-Hodgkin’s, Lymphoma, Total lymphoid irradiation",
author = "Shoji Kutsuki and Uematsu Minoru and Makoto Kondo and Naoyuki Shigematsu and Osamu Kawaguti and Takatsugu Kawase and Akitomo Sugawara and Hisao Ito and Atsushi Kubo",
year = "2000",
doi = "10.11182/jastro1989.12.131",
language = "English",
volume = "12",
pages = "131--136",
journal = "Journal of JASTRO",
issn = "1040-9564",
publisher = "Editorial Board of JASTRO",
number = "2",

}

TY - JOUR

T1 - Radiation therapy for early stage low grade non-hodgkins lymphoma of nodal presentation

AU - Kutsuki, Shoji

AU - Minoru, Uematsu

AU - Kondo, Makoto

AU - Shigematsu, Naoyuki

AU - Kawaguti, Osamu

AU - Kawase, Takatsugu

AU - Sugawara, Akitomo

AU - Ito, Hisao

AU - Kubo, Atsushi

PY - 2000

Y1 - 2000

N2 - Purpose: Radiation therapy is the treatment of choice for early stage low grade non-Hodgkin’s lymphoma (ESLGNHL) of nodal presentation. However, the optimal radiation field is still controversial. We used various radiation fields for this low grade malignancy, and evaluated the results. Materials and methods: Between 1983 and 1993, 14 patients with ESLGNHL were treated with radiation therapy. Five of them received involved field (IF) radiation, 4 regional irradiation (RF), and 5 total lymphoid irradiation (TLI). Results: With a median follow up period of 10 years, 8 of the 14 patients were alive and disease free. Relapse occured in 2 of 5 patients treated with IF, 2 of 4 with RF, and 2 of 5 with TLI. Two patients relapsed following IF had marginal failure, and were salvaged by additional radiation therapy. One patient relapsed following RF had transdiaphragmatic nodal failure, one patient followed TLI relapsed in a non-irradiated area caused by field-matching error. Only one patient with histological transformation into aggressive lymphoma died of disease, and the remaining 5 relapsed patients were alive with or without ESLGNHL. Conclusion: Larger field radiation therapy may reduce nodal and/or marginal failure in patients with ESLGNHL. However without histologic transformation, relapse of ESLGNHL could be salvaged by additional treatment.

AB - Purpose: Radiation therapy is the treatment of choice for early stage low grade non-Hodgkin’s lymphoma (ESLGNHL) of nodal presentation. However, the optimal radiation field is still controversial. We used various radiation fields for this low grade malignancy, and evaluated the results. Materials and methods: Between 1983 and 1993, 14 patients with ESLGNHL were treated with radiation therapy. Five of them received involved field (IF) radiation, 4 regional irradiation (RF), and 5 total lymphoid irradiation (TLI). Results: With a median follow up period of 10 years, 8 of the 14 patients were alive and disease free. Relapse occured in 2 of 5 patients treated with IF, 2 of 4 with RF, and 2 of 5 with TLI. Two patients relapsed following IF had marginal failure, and were salvaged by additional radiation therapy. One patient relapsed following RF had transdiaphragmatic nodal failure, one patient followed TLI relapsed in a non-irradiated area caused by field-matching error. Only one patient with histological transformation into aggressive lymphoma died of disease, and the remaining 5 relapsed patients were alive with or without ESLGNHL. Conclusion: Larger field radiation therapy may reduce nodal and/or marginal failure in patients with ESLGNHL. However without histologic transformation, relapse of ESLGNHL could be salvaged by additional treatment.

KW - Early stage low grade non-Hodgkin’s

KW - Lymphoma

KW - Total lymphoid irradiation

UR - http://www.scopus.com/inward/record.url?scp=84958255323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958255323&partnerID=8YFLogxK

U2 - 10.11182/jastro1989.12.131

DO - 10.11182/jastro1989.12.131

M3 - Article

VL - 12

SP - 131

EP - 136

JO - Journal of JASTRO

JF - Journal of JASTRO

SN - 1040-9564

IS - 2

ER -